Myxedema coma.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D003128:Coma / Q000188:drug therapy / Q000209:etiology*; D004630:Emergencies; D006801:Humans; D007010:Hyponatremia / Q000628:therapy; D007022:Hypotension / Q000628:therapy; D007035:Hypothermia / Q000628:therapy; D007037:Hypothyroidism / Q000150:complications; D007275:Injections, Intravenous; D008722:Methods; D009230:Myxedema / Q000150:complications* / Q000188:drug therapy; D011379:Prognosis; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014284:Triiodothyronine; D013974:Thyroxine